| Direct α-heteroarylation of amides (α to nitrogen) and ethers through a benzaldehyde-mediated photoredox reaction Y Zhang, KB Teuscher, H Ji Chemical Science 7 (3), 2111-2118, 2016 | 111 | 2016 |
| Discovery and structure-based optimization of potent and selective WD repeat domain 5 (WDR5) inhibitors containing a dihydroisoquinolinone bicyclic core J Tian, KB Teuscher, ER Aho, JR Alvarado, JJ Mills, KM Meyers, ... Journal of medicinal chemistry 63 (2), 656-675, 2019 | 51 | 2019 |
| Structure-based design of 1, 4-dibenzoylpiperazines as β-catenin/B-cell lymphoma 9 protein–protein interaction inhibitors JA Wisniewski, J Yin, KB Teuscher, M Zhang, H Ji ACS medicinal chemistry letters 7 (5), 508-513, 2016 | 47 | 2016 |
| A versatile method to determine the cellular bioavailability of small-molecule inhibitors KB Teuscher, M Zhang, H Ji Journal of medicinal chemistry 60 (1), 157-169, 2017 | 38 | 2017 |
| Discovery of potent orally bioavailable WD repeat domain 5 (WDR5) inhibitors using a pharmacophore-based optimization KB Teuscher, KM Meyers, Q Wei, JJ Mills, J Tian, J Alvarado, J Sai, ... Journal of medicinal chemistry 65 (8), 6287-6312, 2022 | 22 | 2022 |
| Fragment-based discovery of small molecules bound to T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) TA Rietz, KB Teuscher, JJ Mills, RD Gogliotti, LT Lepovitz, WR Scaggs, ... Journal of medicinal chemistry 64 (19), 14757-14772, 2021 | 22 | 2021 |
| Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models KB Teuscher, S Chowdhury, KM Meyers, J Tian, J Sai, M Van Meveren, ... Proceedings of the National Academy of Sciences 120 (1), e2211297120, 2023 | 16 | 2023 |
| Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interaction Z Li, M Zhang, KB Teuscher, H Ji Journal of Medicinal Chemistry 64 (15), 11195-11218, 2021 | 10 | 2021 |
| Structure-based discovery of potent, orally bioavailable benzoxazepinone-based WD repeat domain 5 inhibitors KB Teuscher, JJ Mills, J Tian, C Han, KM Meyers, J Sai, TM South, ... Journal of Medicinal Chemistry 66 (24), 16783-16806, 2023 | 4 | 2023 |
| Protocol for fragment hopping KB Teuscher, H Ji Fragment-Based Methods in Drug Discovery, 57-73, 2015 | 4 | 2015 |
| Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies CT Meyer, BN Smith, J Wang, KB Teuscher, BC Grieb, GC Howard, ... Proceedings of the National Academy of Sciences 121 (35), e2408889121, 2024 | 1 | 2024 |
| Wdr5 inhibitors and modulators T Lee, KB Teuscher, S Chowdhury, T Jianhua, KM Meyers, SW Fesik US Patent App. 18/559,184, 2024 | | 2024 |
| WDR5 inhibitors and modulators T Lee, JR Alvarado, T Jianhua, KM Meyers, HAN Changho, JJ Mills, ... US Patent 11,999,716, 2024 | | 2024 |
| Wdr5 inhibitors and modulators T Lee, KB Teuscher, T Jianhua, KM Meyers, S Chowdhury, SW Fesik US Patent App. 17/775,174, 2023 | | 2023 |
| Wdr5 inhibitors and modulators T Lee, HAN Changho, JJ Mills, KB Teuscher, T Jianhua, KM Meyers, ... US Patent App. 17/613,717, 2022 | | 2022 |
| Cellular Bioavailability of Small-molecule Inhibitors and Optimization of Small-molecule Inhibitors for β-Catenin Mediated Protein–protein Interactions KB Teuscher The University of Utah, 2018 | | 2018 |
| Direct a-heteroarylation of amides (a to nitrogen) and ethers through a benzaldehyde-mediated photoredox reaction Y Zhang, KB Teuscher, H Ji | | |
